Repeated-testing of place preference expression for evaluation of anti-craving-drug effects

Amino Acids

Volumn 28, Issue 3, 2005, Pages 309-317

  Herzig, V ^a   Schmidt, W J ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Acamprosate; Cocaine; Conditioned place preference (CPP) expression; Conditioned reward; Morphine; Naloxone; Repeated testing

Indexed keywords

ACAMPROSATE; COCAINE; MORPHINE; NALOXONE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; MALE; METHODOLOGY; MORPHINE ADDICTION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE; WITHDRAWAL SYNDROME;

ALCOHOL DETERRENTS; ANALGESICS, OPIOID; ANESTHETICS, LOCAL; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; CONDITIONING (PSYCHOLOGY); DRUG EVALUATION, PRECLINICAL; MALE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; TAURINE;

ANIMALIA;

EID: 20044386155     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-005-0185-x     Document Type: Article

References (32)

1. Alderson HL, Robbins TW, Everitt BJ (2000) Heroin self-administration under a second-order schedule of reinforcement: acquisition and maintenance of heroin-seeking behaviour in rats. Psychopharmacology (Berl) 153: 120-133
2. Bardo MT, Neisewander JL (1986) Single-trial conditioned place preference using intravenous morphine. Pharmacol Biochem Behav 25: 1101-1105
3. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP (1999) Limbic activation during cue-induced cocaine craving. Am J Psychiatry 156: 11-18
4. Comer SD, Lac ST, Curtis LK, Carroll ME (1993) Effects of buprenorphine and naltrexone on reinstatement of cocaine- reinforced responding in rats. J Pharmacol Exp Ther 267: 1470-1477
5. Cunningham CL, Henderson CM, Bormann NM (1998) Extinction of ethanol-induced conditioned place preference and conditioned place aversion: effects of naloxone. Psychopharmacology (Berl) 139: 62-70
6. Herzig V, Schmidt WJ (2004) Effects of MPEP on locomotion, sensitization and conditioned reward induced by cocaine or morphine. Neuropharmacology 47: 973-984
7. Herzig V, Schmidt WJ (2005) Anti-craving drugs acamprosate and naloxone do not reduce expression of morphine conditioned place preference in isolated and group-housed rats. Neurosci Lett 374: 119-123
8. Kiefer F, Jahn H, Tarnaske T, Helwig H, Briken P, Holzbach R, Kampf P, Stracke R, Baehr M, Naber D, Wiedemann K (2003) Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry 60: 92-99
9. Kim SG, Han BD, Park JM, Kim MJ, Stromberg MF (2004) Effect of the combination of naltrexone and acamprosate on alcohol intake in mice. Psychiatry Clin Neurosci 58: 30-36
10. Kotlinska J, Biala G (1999) Effects of the NMDA/glycine receptor antagonist, L-701,324, on morphine- and cocaine-induced place preference. Pol J Pharmacol 51: 323-330
11. Kratzer U, Schmidt WJ (1998) The anti-craving-drug acamprosate inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats. Neurosci Lett 252: 53-56
12. Kratzer U, Spanagel R, Schmidt WJ (2003) The effect of acamprosate on the development of morphine-induced behavioural sensitization in rats. Behav Pharmacol 14: 351-356
13. McGeehan AJ, Olive MF (2003) The anti-relapse compound acamprosate inhibits the development of a conditioned place preference to ethanol and cocaine but not morphine. Br J Pharmacol 138: 9-12
14. Mucha RF, van der Kooy D, O'Shaughnessy M, Bucenieks P (1982) Drug reinforcement studied by the use of place conditioning in rat. Brain Res 243: 91-105
15. Mueller D, Stewart J (2000) Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction. Behav Brain Res 115: 39-47
16. Mueller D, Perdikaris D, Stewart J (2002) Persistence and drug-induced reinstatement of a morphine-induced conditioned place preference. Behav Brain Res 136: 389-397
17. Neisewander JL, Pierce RC, Bardo MT (1990) Naloxone enhances the expression of morphine-induced conditioned place preference. Psychopharmacology (Berl) 100: 201-205
18. Noble F, Fournie-Zaluski MC, Roques BP (1993) Unlike morphine the endogenous enkephalins protected by RB101 are unable to establish a conditioned place preference in mice. Eur J Pharmacol 230: 139-149
19. Olmstead MC, Franklin KB (1997) The development of a conditioned place preference to morphine: effects of micro injections into various CNS sites. Behav Neurosci 111: 1324-1334
20. Papp M, Gruca P, Willner P (2002) Selective blockade of drug-induced place preference conditioning by ACPC, a functional NDMA-receptor antagonist. Neuropsychopharmacology 27: 727-743
21. Pascucci T, Cioli I, Pisetzky F, Dupre S, Spirito A, Nencini P (1999) Acamprosate does not antagonise the discriminative stimulus properties of amphetamine and morphine in rats. Pharmacol Res 40: 333-338
22. Popik P, Danysz W (1997) Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine. J Pharmacol Exp Ther 280: 854-865
23. Popik P, Kolasiewicz W (1999) Mesolimbic NMDA receptors are implicated in the expression of conditioned morphine reward. N-S Arch Pharmacol 359: 288-294
24. Popik P, Wrobel M, Rygula R, Bisaga A, Bespalov AY (2003) Effects of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforcers in mice. Behav Pharmacol 14: 237-244
25. Sepulveda J, Ortega A, Zapata G, Contreras E (2002) Acamprosate decreases the induction of tolerance and physical dependence in morphine-treated mice. Eur J Pharmacol 445: 87-91
26. Shaham Y, Stewart J (1996) Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in rats. Psychopharmacology (Berl) 125: 385-391
27. Spanagel R, Zieglgänsberger W (1997) Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 18: 54-59
28. Spanagel R, Holter SM, Allingham K, Landgraf R, Zieglgänsberger W (1996) Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. Eur J Pharmacol 305: 39-44
29. Spanagel R, Sillaber I, Zieglgänsberger W, Corrigall WA, Stewart J, Shaham Y (1998) Acamprosate suppresses the expression of morphine-induced sensitization in rats but does not affect heroin self-administration or relapse induced by heroin or stress. Psychopharmacology (Berl) 139: 391-401
30. Stewart J (1983) Conditioned and unconditioned drug effects in relapse to opiate and stimulant drug self-adminstration. Prog Neuropsychopharmacol Biol Psychiatry 7: 591-597
31. Stromberg MF, Mackler SA, Volpicelli JR, O'Brien CP (2001) Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption. Alcohol 23: 109-116
32. Tzschentke TM, Schmidt WJ (1997) Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization. Behav Brain Res 84: 99-107